Pharma in Focus - knowledge is power

27 May - 2 Jun 2013

Special Report: Australia's growing anti-pharma campaign
Medicines Australia has long argued that Australia should be proud of its pharma industry, saying the industry contributes significantly to mitigation of disease and delivers economic benefits but, it seems, that message is hard to get through

Where to now for generic hopes?
The generics side of pharma has been calling for volume drivers to make up for shrinking PBS prices for the drugs it sells but the government shows no sign of noticing

How to access Pharma in Focus articles

If you're a current subscriber, See below
If you're new to Pharma in Focus, Click here
If you haven't SUBSCRIBED yet, Click here

Current Subscribers

If you are are current Full Text Subscriber or have taken out a Free Trial, please type your email address into the form below.

This will restore your access and return you to the Home Page.

Drugs approvals to slow in 2013
..full report

Bayer Berocca case dismissed
..full report

GSK NZ calls in Varilrix from EU
..full report

PBS diabetes meds review opens
..full report

Smoking drug benefits outweigh risks
..full report

Pharmac finalises hospital list
..full report

Latest trials: GSK's new contract
..full report

Latest ARTG registrations
..full report